As of the latest Form 4 filed Jul 10, 2026.
What Nuvalent Inc insiders — officers, directors and 10% owners — have bought and sold in their own stock, straight from their SEC Form 4 filings. Values are shares × the reported transaction price where both are disclosed.
Buys plotted up, sells down; bar height is the disclosed dollar value (shares × reported price). Our Form 4 history is only complete from mid-2026, so early months are sparse — the series fills in as more filings land. Open-market purchases and sales only.
Newest filing first — the 85 most recent filings for NUVL.
| Filed | Trade date | Insider | Transaction | Shares | Price | Value | 10b5-1 | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-07-10 | 2026-07-09 | Pelish Henry E. Chief Scientific Officer | SSale | −2.11K | $123.81 | $261K | Yes (planned) | Form 4 ↗ |
| 2026-07-08 | 2026-07-06 | Porter James Richard President and CEO | SSale | −30.0K | $123.72 | $3.71M | Yes (planned) | Form 4 ↗ |
| 2026-07-08 | 2026-07-06 | Porter James Richard, President and CEO | MExercise | +30.0K | $18.93 | $568K | Yes (planned) | Form 4 ↗ |
| 2026-07-01 | 2026-06-29 | Noci Darlene Chief Development Officer | SSale | −5.50K | $123.51 | $679K | Yes (planned) | Form 4 ↗ |
| 2026-07-01 | 2026-06-29 | Noci Darlene, Chief Development Officer | MExercise | +5.50K | $27.85 | $153K | Yes (planned) | Form 4 ↗ |
| 2026-06-18 | 2026-06-16 | Oliger Christy J. Director | AAward | +3.44K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-06-18 | 2026-06-16 | Wheeler Cameron Director | AAward | +3.44K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-06-18 | 2026-06-16 | Meyers Michael L. Director | AAward | +3.44K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-06-18 | 2026-06-16 | Bogle Grant C. Director | AAward | +3.44K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-06-18 | 2026-06-16 | Srivastava Sapna Director | AAward | +3.44K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-06-18 | 2026-06-16 | Squarer Ron Director | AAward | +3.44K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-06-18 | 2026-06-16 | Protopapas Anna Director | AAward | +3.44K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-06-18 | 2026-06-16 | Flynn James E Director | AAward | +3.44K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-06-11 | 2026-06-09 | Noci Darlene Chief Development Officer | SSale | −20.0K | $122.81 | $2.46M | Yes (planned) | Form 4 ↗ |
| 2026-06-11 | 2026-06-09 | Noci Darlene, Chief Development Officer | MExercise | +9.31K | $18.93 | $176K | Yes (planned) | Form 4 ↗ |
| 2026-06-11 | 2026-06-09 | Noci Darlene, Chief Development Officer | MExercise | +685.00 | $6.89 | $4.72K | Yes (planned) | Form 4 ↗ |
| 2026-06-11 | 2026-06-09 | Noci Darlene, Chief Development Officer | MExercise | +10.0K | $1.08 | $10.8K | Yes (planned) | Form 4 ↗ |
| 2026-06-10 | 2026-06-08 | Porter James Richard President and CEO | SSale | −3.04K | $89.63 | $272K | Yes (planned) | Form 4 ↗ |
| 2026-06-10 | 2026-06-08 | Porter James Richard, President and CEO | SSale | −14.5K | $88.79 | $1.28M | Yes (planned) | Form 4 ↗ |
| 2026-06-10 | 2026-06-08 | Porter James Richard, President and CEO | SSale | −12.5K | $87.97 | $1.10M | Yes (planned) | Form 4 ↗ |
| 2026-06-10 | 2026-06-08 | Porter James Richard, President and CEO | MExercise | +30.0K | $18.93 | $568K | Yes (planned) | Form 4 ↗ |
| 2026-06-03 | 2026-06-01 | Balcom Alexandra Chief Financial Officer | SSale | −200.00 | $103.84 | $20.8K | Yes (planned) | Form 4 ↗ |
| 2026-06-03 | 2026-06-01 | Balcom Alexandra, Chief Financial Officer | SSale | −279.00 | $101.79 | $28.4K | Yes (planned) | Form 4 ↗ |
| 2026-06-03 | 2026-06-01 | Balcom Alexandra, Chief Financial Officer | SSale | −2.59K | $100.65 | $260K | Yes (planned) | Form 4 ↗ |
| 2026-06-03 | 2026-06-01 | Balcom Alexandra, Chief Financial Officer | SSale | −3.13K | $99.86 | $313K | Yes (planned) | Form 4 ↗ |
| 2026-06-03 | 2026-06-01 | Balcom Alexandra, Chief Financial Officer | SSale | −1.20K | $98.57 | $118K | Yes (planned) | Form 4 ↗ |
| 2026-06-03 | 2026-06-01 | Balcom Alexandra, Chief Financial Officer | SSale | −900.00 | $97.68 | $87.9K | Yes (planned) | Form 4 ↗ |
| 2026-06-03 | 2026-06-01 | Balcom Alexandra, Chief Financial Officer | SSale | −2.17K | $95.99 | $208K | Yes (planned) | Form 4 ↗ |
| 2026-06-03 | 2026-06-01 | Balcom Alexandra, Chief Financial Officer | SSale | −960.00 | $94.87 | $91.1K | Yes (planned) | Form 4 ↗ |
| 2026-06-03 | 2026-06-01 | Balcom Alexandra, Chief Financial Officer | MExercise | +11.4K | $6.89 | $78.8K | Yes (planned) | Form 4 ↗ |
| 2026-06-01 | 2026-05-28 | Miller Deborah Ann Chief Legal Officer | SSale | −1.67K | $109.30 | $182K | Yes (planned) | Form 4 ↗ |
| 2026-06-01 | 2026-05-28 | Miller Deborah Ann, Chief Legal Officer | SSale | −900.00 | $108.14 | $97.3K | Yes (planned) | Form 4 ↗ |
| 2026-06-01 | 2026-05-28 | Miller Deborah Ann, Chief Legal Officer | SSale | −1.53K | $107.45 | $164K | Yes (planned) | Form 4 ↗ |
| 2026-06-01 | 2026-05-28 | Miller Deborah Ann, Chief Legal Officer | SSale | −1.40K | $106.32 | $149K | Yes (planned) | Form 4 ↗ |
| 2026-06-01 | 2026-05-28 | Miller Deborah Ann, Chief Legal Officer | MExercise | +5.50K | $6.89 | $37.9K | Yes (planned) | Form 4 ↗ |
| 2026-06-01 | 2026-05-28 | Noci Darlene Chief Development Officer | SSale | −100.00 | $109.76 | $11.0K | Yes (planned) | Form 4 ↗ |
| 2026-06-01 | 2026-05-28 | Noci Darlene, Chief Development Officer | SSale | −1.50K | $109.30 | $164K | Yes (planned) | Form 4 ↗ |
| 2026-06-01 | 2026-05-28 | Noci Darlene, Chief Development Officer | SSale | −1.18K | $108.01 | $127K | Yes (planned) | Form 4 ↗ |
| 2026-06-01 | 2026-05-28 | Noci Darlene, Chief Development Officer | SSale | −1.42K | $107.33 | $153K | Yes (planned) | Form 4 ↗ |
| 2026-06-01 | 2026-05-28 | Noci Darlene, Chief Development Officer | SSale | −1.30K | $106.26 | $138K | Yes (planned) | Form 4 ↗ |
| 2026-06-01 | 2026-05-28 | Noci Darlene, Chief Development Officer | MExercise | +5.50K | $27.85 | $153K | Yes (planned) | Form 4 ↗ |
| 2026-05-06 | 2026-05-04 | Porter James Richard President and CEO | SSale | −2.11K | $102.88 | $217K | Yes (planned) | Form 4 ↗ |
| 2026-05-06 | 2026-05-04 | Porter James Richard, President and CEO | SSale | −17.4K | $102.10 | $1.77M | Yes (planned) | Form 4 ↗ |
| 2026-05-06 | 2026-05-04 | Porter James Richard, President and CEO | SSale | −7.43K | $101.48 | $754K | Yes (planned) | Form 4 ↗ |
| 2026-05-06 | 2026-05-04 | Porter James Richard, President and CEO | SSale | −1.41K | $99.77 | $140K | Yes (planned) | Form 4 ↗ |
| 2026-05-06 | 2026-05-04 | Porter James Richard, President and CEO | SSale | −1.70K | $98.54 | $167K | Yes (planned) | Form 4 ↗ |
| 2026-05-06 | 2026-05-04 | Porter James Richard, President and CEO | MExercise | +30.0K | $18.93 | $568K | Yes (planned) | Form 4 ↗ |
| 2026-05-01 | 2026-04-30 | Miller Deborah Ann Chief Legal Officer | SSale | −1.08K | $99.57 | $108K | Yes (planned) | Form 4 ↗ |
| 2026-05-01 | 2026-04-30 | Miller Deborah Ann, Chief Legal Officer | SSale | −4.42K | $99.13 | $438K | Yes (planned) | Form 4 ↗ |
| 2026-05-01 | 2026-04-30 | Miller Deborah Ann, Chief Legal Officer | MExercise | +5.50K | $6.89 | $37.9K | Yes (planned) | Form 4 ↗ |
| 2026-05-01 | 2026-04-29 | Noci Darlene Chief Development Officer | SSale | −300.00 | $101.17 | $30.4K | Yes (planned) | Form 4 ↗ |
| 2026-05-01 | 2026-04-29 | Noci Darlene, Chief Development Officer | SSale | −700.00 | $100.14 | $70.1K | Yes (planned) | Form 4 ↗ |
| 2026-05-01 | 2026-04-29 | Noci Darlene, Chief Development Officer | SSale | −4.50K | $99.35 | $447K | Yes (planned) | Form 4 ↗ |
| 2026-05-01 | 2026-04-29 | Noci Darlene, Chief Development Officer | MExercise | +5.50K | $27.85 | $153K | Yes (planned) | Form 4 ↗ |
| 2026-04-13 | 2026-04-09 | Pelish Henry E. Chief Scientific Officer | SSale | −900.00 | $105.00 | $94.5K | Yes (planned) | Form 4 ↗ |
| 2026-04-13 | 2026-04-09 | Pelish Henry E., Chief Scientific Officer | SSale | −2.19K | $104.27 | $229K | Yes (planned) | Form 4 ↗ |
| 2026-04-13 | 2026-04-09 | Pelish Henry E., Chief Scientific Officer | MExercise | +3.09K | $27.85 | $86.1K | Yes (planned) | Form 4 ↗ |
| 2026-04-08 | 2026-04-06 | Porter James Richard President and CEO | SSale | −100.00 | $105.60 | $10.6K | Yes (planned) | Form 4 ↗ |
| 2026-04-08 | 2026-04-06 | Porter James Richard, President and CEO | SSale | −6.12K | $104.78 | $641K | Yes (planned) | Form 4 ↗ |
| 2026-04-08 | 2026-04-06 | Porter James Richard, President and CEO | SSale | −12.4K | $103.78 | $1.29M | Yes (planned) | Form 4 ↗ |
| 2026-04-08 | 2026-04-06 | Porter James Richard, President and CEO | SSale | −11.4K | $103.21 | $1.17M | Yes (planned) | Form 4 ↗ |
| 2026-04-08 | 2026-04-06 | Porter James Richard, President and CEO | MExercise | +16.3K | $27.85 | $454K | Yes (planned) | Form 4 ↗ |
| 2026-04-08 | 2026-04-06 | Porter James Richard, President and CEO | MExercise | +13.7K | $18.93 | $260K | Yes (planned) | Form 4 ↗ |
| 2026-04-01 | 2026-03-30 | Noci Darlene Chief Development Officer | SSale | −2.97K | $98.13 | $291K | Yes (planned) | Form 4 ↗ |
| 2026-04-01 | 2026-03-30 | Noci Darlene, Chief Development Officer | SSale | −2.53K | $97.43 | $247K | Yes (planned) | Form 4 ↗ |
| 2026-04-01 | 2026-03-30 | Noci Darlene, Chief Development Officer | MExercise | +5.50K | $27.85 | $153K | Yes (planned) | Form 4 ↗ |
| 2026-03-30 | 2026-03-26 | Miller Deborah Ann Chief Legal Officer | SSale | −2.80K | $99.46 | $279K | Yes (planned) | Form 4 ↗ |
| 2026-03-30 | 2026-03-26 | Miller Deborah Ann, Chief Legal Officer | SSale | −1.76K | $98.21 | $173K | Yes (planned) | Form 4 ↗ |
| 2026-03-30 | 2026-03-26 | Miller Deborah Ann, Chief Legal Officer | SSale | −940.00 | $97.50 | $91.7K | Yes (planned) | Form 4 ↗ |
| 2026-03-30 | 2026-03-26 | Miller Deborah Ann, Chief Legal Officer | MExercise | +5.50K | $6.89 | $37.9K | Yes (planned) | Form 4 ↗ |
| 2026-03-26 | 2026-03-25 | Balcom Alexandra Chief Financial Officer | SSale | −13.7K | $100.16 | $1.37M | Yes (planned) | Form 4 ↗ |
| 2026-03-26 | 2026-03-24 | Balcom Alexandra, Chief Financial Officer | SSale | −1.16K | $96.50 | $112K | Yes (planned) | Form 4 ↗ |
| 2026-03-26 | 2026-03-24 | Balcom Alexandra, Chief Financial Officer | SSale | −7.67K | $95.88 | $735K | Yes (planned) | Form 4 ↗ |
| 2026-03-26 | 2026-03-24 | Balcom Alexandra, Chief Financial Officer | SSale | −2.60K | $95.03 | $247K | Yes (planned) | Form 4 ↗ |
| 2026-03-26 | 2026-03-24 | Balcom Alexandra, Chief Financial Officer | MExercise | +11.4K | $1.08 | $12.3K | Yes (planned) | Form 4 ↗ |
| 2026-03-16 | 2026-03-13 | Pelish Henry E. Chief Scientific Officer | SSale | −1.70K | $99.71 | $170K | Yes (planned) | Form 4 ↗ |
| 2026-03-16 | 2026-03-13 | Pelish Henry E., Chief Scientific Officer | SSale | −2.60K | $98.83 | $257K | Yes (planned) | Form 4 ↗ |
| 2026-03-16 | 2026-03-13 | Pelish Henry E., Chief Scientific Officer | SSale | −804.00 | $97.89 | $78.7K | Yes (planned) | Form 4 ↗ |
| 2026-03-16 | 2026-03-12 | Pelish Henry E., Chief Scientific Officer | SSale | −306.00 | $99.12 | $30.3K | Yes (planned) | Form 4 ↗ |
| 2026-03-16 | 2026-03-12 | Pelish Henry E., Chief Scientific Officer | SSale | −5.50K | $98.44 | $542K | Yes (planned) | Form 4 ↗ |
| 2026-03-16 | 2026-03-12 | Pelish Henry E., Chief Scientific Officer | SSale | −24.2K | $97.79 | $2.37M | Yes (planned) | Form 4 ↗ |
| 2026-03-16 | 2026-03-12 | Pelish Henry E., Chief Scientific Officer | MExercise | +2.98K | $72.35 | $216K | Yes (planned) | Form 4 ↗ |
| 2026-03-16 | 2026-03-12 | Pelish Henry E., Chief Scientific Officer | MExercise | +4.13K | $29.33 | $121K | Yes (planned) | Form 4 ↗ |
| 2026-03-16 | 2026-03-12 | Pelish Henry E., Chief Scientific Officer | MExercise | +1.75K | $27.85 | $48.8K | Yes (planned) | Form 4 ↗ |
| 2026-03-16 | 2026-03-12 | Pelish Henry E., Chief Scientific Officer | MExercise | +8.46K | $18.93 | $160K | Yes (planned) | Form 4 ↗ |
Insiders — a company’s officers, directors and holders of more than 10% of its stock — must report any trade in that stock to the SEC on a Form 4 within two business days. Each row here is one transaction from those filings.
The transaction code tells you what happened: Purchase (P) and Sale (S) are open-market trades — the ones markets watch most; Award (A) is a granted stock or unit, Option exercise (M) converts options into shares, and Gift (G) is a transfer for no consideration. Awards, exercises and gifts are largely compensation or administrative, not a directional bet.
One caveat on sales: many are made under a Rule 10b5-1 plan scheduled months in advance, so a sale is not automatically a bearish signal. Insider activity is a noisy input — read it alongside the filings, not on its own.
See also NUVL’s full analysis or the market-wide insider trading feed. The tabs above jump to NUVL’s other SEC data.
Source: SEC Form 4 filings for NUVL, parsed from EDGAR. Transaction prices are as reported in the filing — SEC public-domain data, not market quotes. Values are shares × reported price where both are disclosed; grants and gifts often carry no price. A delayed record of what insiders reported, not a live position or a recommendation.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.